Cita Health Care Inc., operating under MRZ, successfully held the HLA-AB Single Antigen, HLA-SSO, and MR SPOT 2 device introduction demo at the Radisson Blu Asia Hotel between September 23–25, 2024, with the participation of esteemed physicians working in tissue typing laboratories from various provinces across Türkiye.





